2020 Drug Metabolism Gordon Research Conference and Seminar
2020 Drug Metabolism Gordon Research Conference and Seminar
批准号:
10063328
负责人:
JAMES STEVEN LEEDER
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-05 至 2022-09-04
关键词:
AcademiaAddressAnalytical ChemistryAnniversaryAtmosphereBig DataCYP2D6 geneCareer ChoiceCellsChemistryClinicalClinical PharmacologyClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsComputer ModelsCytochrome P450DataDevelopmentDisciplineDoseDrug IndustryDrug KineticsEnvironmentEnzymatic BiochemistryExposure toFutureGenetic PolymorphismGrowthHearingHourIn VitroIndividualIndustryKnowledgeLearningMass Spectrum AnalysisMembrane Transport ProteinsMentorsMentorshipMetabolismMicrofluidicsModelingMolecular BiologyNatureOralOutcomePatientsPharmaceutical PreparationsPharmacodynamicsPharmacology and ToxicologyPopulationPostdoctoral FellowPrecision therapeuticsProcessPropertyRecommendationResearchResearch PersonnelRoleScienceScientific Advances and AccomplishmentsScientistSeminalTechniquesTechnologyTestingTherapeutic AgentsTimeUpdateWomanWorkabsorptioncareercareer developmentdesigndrug developmentdrug discoverydrug dispositiondrug metabolismexperiencegraduate studentin vitro activityin vivoinnovationinsightinterestmeetingsmicrobiomenovelnovel therapeuticspatient populationpostersprecision medicinereconstitutionstem cellssymposiumtherapeutic siRNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The 50th Drug Metabolism Gordon Research Conference (GRC) in 2020 will highlightunpublished, cutting-edge
research patients as unique
individuals, rather than populations, as a preparatory step to delivering precision therapeutics.
that celebrates advances in the field over the past 50 years, with an emphasis on
An essential
component of the knowledge to be acquired is a clear understanding of the absorption, distribution, metabolism,
and elimination (ADME) properties of the drug. The 2020 conference will include a keynote presentation on the
integration of drug metabolism science and big data to inform precision medicine, and in celebration of the 50th
anniversary the scientific sessions will provide cutting-edge contemporary updates on topics discussed at the
first Drug Metabolism GRC, such as drug metabolism by the microbiome, mechanisms of drug metabolism and
extrapolation of in vitro data to drug metabolism in vivo. Topics, such as membrane transporters, technologies
like mass spectrometry and novel therapeutics entities, such as siRNA-based therapeutic agents unknown in
1971 will also be discussed. As expected for GRCs all presentations will include unpublished data, with sessions
designed for maximal audience participation and discussion. Attendees are encouraged to submit posters for
display at the poster sessions organized by the Vice Chair Dr. Jane Kenny. Posters are viewed during a 2-hour
session every day of the conference which provides ample time for interaction. The Wednesday evening session
will feature oral presentations by young investigators (graduate students, postdoctoral trainees and early career
scientists) selected from the submitted poster abstracts. The conference is collegial and informal in nature, with
ample opportunity to discuss unpublished research, make collaborative connections, and develop new ideas.
Young investigators have easy access to mentoring from established investigators, as well as during informal
career advice discussions planned during the week. There will be a session featuring an open discussion of
challenges faced by women in science during the meeting led by two early career women scientists. Overall,
the meeting will provide an opportunity for researchers in the ADME field to hear cutting edge science and have
in depth discussions with colleagues that will facilitate collaboration, career development and learning.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids
-
批准号:9976562
-
项目类别:
-
资助金额:$68.79万
-
财政年份:2016
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids
-
批准号:9229379
-
项目类别:
-
资助金额:$72.61万
-
财政年份:2016
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Pediatric Pharmacogenomics and Personalized Medicine
-
批准号:8532008
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Exogenous and Endogenous Biomarkers of CYP2D6 Variability in Pediatrics
-
批准号:7760776
-
项目类别:
-
资助金额:$53.98万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Pediatric Pharmacogenomics and Personalized Medicine
-
批准号:8399999
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Pediatric Pharmacogenomics and Personalized Medicine
-
批准号:7916046
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Exogenous and Endogenous Biomarkers of CYP2D6 Variability in Pediatrics
-
批准号:8609045
-
项目类别:
-
资助金额:$56.17万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Exogenous and Endogenous Biomarkers of CYP2D6 Variability in Pediatrics
-
批准号:8249003
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Pediatric Pharmacogenomics and Personalized Medicine
-
批准号:8049627
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Exogenous and Endogenous Biomarkers of CYP2D6 Variability in Pediatrics
-
批准号:8437174
-
项目类别:
-
资助金额:$51.97万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Exogenous and Endogenous Biomarkers of CYP2D6 Variability in Pediatrics
-
批准号:8049734
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2010
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Ontogeny of Drug Bioactivation and Idiosyncratic ADRs
-
批准号:6897475
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2003
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Ontogeny of Drug Bioactivation and Idiosyncratic ADRs
-
批准号:7234434
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2003
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Ontogeny of Drug Bioactivation and Idiosyncratic ADRs
-
批准号:6751318
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2003
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Ontogeny of Drug Bioactivation and Idiosyncratic ADRs
-
批准号:6631181
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2003
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
Ontogeny of Drug Bioactivation and Idiosyncratic ADRs
-
批准号:7071069
-
项目类别:
-
资助金额:$29.44万
-
财政年份:2003
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
PATHOGENESIS OF ANTICONVULSANT HYPERSENSITIVITY SYNDROME
-
批准号:6386397
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2000
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
PATHOGENESIS OF ANTICONVULSANT HYPERSENSITIVITY SYNDROME
-
批准号:6519953
-
项目类别:
-
资助金额:$35.29万
-
财政年份:2000
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
PATHOGENESIS OF ANTICONVULSANT HYPERSENSITIVITY SYNDROME
-
批准号:6636276
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2000
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
PATHOGENESIS OF ANTICONVULSANT HYPERSENSITIVITY SYNDROME
-
批准号:6045566
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2000
-
负责人:JAMES STEVEN LEEDER
-
依托单位:
海外基金